Evaluation of blood collection systems
- Conditions
- In this study the influence of the bloodcollectionsystem on laboratory results is studied on a number of specific laboratory tests.
- Registration Number
- NL-OMON20486
- Lead Sponsor
- Medlon b.v.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 105
Inclusion Criteria
Healthy volunteers aged over 18 years (40 subjects)
Patients using vitamin K antagonists (20 subjects), Patients on heparin therapy (20 subjects) Patients with an decreased Von Willebrandfactor activity (5), protein C deficiency (5), protein S deficiency (5), Factor VIII deficiency (5) or factor IX deficiency (5).
Exclusion Criteria
Patients having a decreased hemoglobin (Hb under 7.5 for women and Hb under 8.5 for men)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Two collectionsystems (Greiner Bio-One and Becton Dickinson) are studied for specific laboratorytests. Results are evaluated in accordance to the CLSI Evaluation protocol number 9.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms affect laboratory results in blood collection system studies?
How does blood collection system type influence biomarker stability and detection accuracy?
What are the comparative effects of different anticoagulants on clinical chemistry assays in observational trials?
Which adverse events are associated with blood collection systems in non-invasive clinical research?
How do pre-analytical variables in blood collection impact diagnostic reliability for Medlon b.v. trials?